Home
>
National Drug Code (NDC)
>
Losartan Potassium and Hydrochlorothiazide
Losartan Potassium and Hydrochlorothiazide - 52125-452-19 - (Losartan Potassium and Hydrochlorothiazide)
Drug Information of Losartan Potassium and Hydrochlorothiazide
| Product NDC: | 52125-452 |
| Proprietary Name: | Losartan Potassium and Hydrochlorothiazide |
| Non Proprietary Name: | Losartan Potassium and Hydrochlorothiazide |
| Active Ingredient(s): | 12.5; 100 mg/1; mg/1 & nbsp; Losartan Potassium and Hydrochlorothiazide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Losartan Potassium and Hydrochlorothiazide
| Product NDC: | 52125-452 |
| Labeler Name: | REMEDYREPACK INC. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090528 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130520 |
Package Information of Losartan Potassium and Hydrochlorothiazide
| Package NDC: | 52125-452-19 |
| Package Description: | 90 TABLET in 1 VIAL (52125-452-19) |
NDC Information of Losartan Potassium and Hydrochlorothiazide
| NDC Code | 52125-452-19 |
| Proprietary Name | Losartan Potassium and Hydrochlorothiazide |
| Package Description | 90 TABLET in 1 VIAL (52125-452-19) |
| Product NDC | 52125-452 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Losartan Potassium and Hydrochlorothiazide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20130520 |
| Marketing Category Name | ANDA |
| Labeler Name | REMEDYREPACK INC. |
| Substance Name | HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUM |
| Strength Number | 12.5; 100 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
